An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Kidney international, 96.2019, Nr. 1, S. 231-244, doi:10.1016/j.kint.2019.01.041
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2019
- Creator
-
Sommerer, Claudia
Suwelack, Barbara
Dragun, Duska
Schenker, Peter
Hauser, Ingeborg A.
Witzke, Oliver
Hugo, Christian
Kamar, Nassim
Merville, Pierre
Junge, Martina
Thaiss, Friedrich
Nashan, Björn
- URN
-
urn:nbn:de:hebis:30:3-500760
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sommerer, Claudia
- Suwelack, Barbara
- Dragun, Duska
- Schenker, Peter
- Hauser, Ingeborg A.
- Witzke, Oliver
- Hugo, Christian
- Kamar, Nassim
- Merville, Pierre
- Junge, Martina
- Thaiss, Friedrich
- Nashan, Björn
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2019
Other Objects (12)
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
Immunosuppression with Everolimus in paediatric heart transplantation
Immunosuppression with tacrolimus after experimental and clinical allovessel transplantation
Stable immunosuppression under low-dose Tacrolimus monotherapy is dependent upon immunological regulation
Vergleich der Nierentransplantatfunktion von schnellen und langsamen Tacrolimus-Metabolisierern nach Umstellung auf Everolimus
Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen
Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression
Falsely Elevated Cyclosporine A and Tacrolimus Concentrations due to Reversible Adsorption to Central Venous Catheters
Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial
Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
Immunosuppression with Everolimus in paediatric heart transplantation
Immunosuppression with tacrolimus after experimental and clinical allovessel transplantation
Stable immunosuppression under low-dose Tacrolimus monotherapy is dependent upon immunological regulation
Vergleich der Nierentransplantatfunktion von schnellen und langsamen Tacrolimus-Metabolisierern nach Umstellung auf Everolimus
Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen
Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression
Falsely Elevated Cyclosporine A and Tacrolimus Concentrations due to Reversible Adsorption to Central Venous Catheters
Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial
Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
Immunosuppression with Everolimus in paediatric heart transplantation
Immunosuppression with tacrolimus after experimental and clinical allovessel transplantation
Stable immunosuppression under low-dose Tacrolimus monotherapy is dependent upon immunological regulation
Vergleich der Nierentransplantatfunktion von schnellen und langsamen Tacrolimus-Metabolisierern nach Umstellung auf Everolimus
Impaired Microcirculation in Children After Kidney Transplantation: Everolimus Versus Mycophenolate Based Immunosuppression Regimen
Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression
Falsely Elevated Cyclosporine A and Tacrolimus Concentrations due to Reversible Adsorption to Central Venous Catheters
Early Everolimus-Facilitated Reduced Tacrolimus in Liver Transplantation : Results From the Randomized HEPHAISTOS Trial
Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients